Elan sees sales of prized Tysabri drug rise sharply

DUBLIN (Reuters) - Elan said sales of the multiple sclerosis drug Royalty Pharma wants to get its hands on through its bid for the Irish drugmaker rose by 14 percent year-on-year to $456 million in the first quarter. Elan, involved in a convoluted takeover saga with Royalty for the past two months, rejected a reduced $11.25 per share bid from the U.S. investment company on Monday, saying it grossly undervalued its future prospects. ... via Health News Headlines - Yahoo! News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/04/elan-sees-sales-of-prized-tysabri-drug.html